TPN
Pre-Launchniacinamide; pyridoxine hydrochloride; tyrosine
NDAORALSUSPENSION
Lifecycle
Pre-Launch
Clinical Trials
20
Data completeness
2/8 — Basic
TPN (niacinamide; pyridoxine hydrochloride; tyrosine) is clinical pharmacology tpn electrolytes (multiple electrolyte additive) helps to maintain normal cellular metabolism during tpn (total parenteral nutrition).
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TPN is an oral suspension containing niacinamide, pyridoxine hydrochloride, and tyrosine designed to support nutritional supplementation and cellular metabolism. It functions as a multi-electrolyte and micronutrient additive that maintains normal cellular processes and prevents deficiency symptoms in patients requiring nutritional support. The formulation works by providing essential cations (sodium, potassium, magnesium, calcium) and anions (chloride, acetate) that regulate nerve depolarization, fluid balance, enzymatic function, and metabolic intermediates.
Pre-Launch
Pre-launch stage indicates early-stage commercial build-out with opportunity for foundational team development across regulatory, supply chain, and initial field organization.
Mechanism of Action
CLINICAL PHARMACOLOGY TPN Electrolytes (multiple electrolyte additive) helps to maintain normal cellular metabolism during TPN (total parenteral nutrition). Providing electrolytes in appropriate amounts prevents deficiency symptoms which otherwise would occur in their absence. Cations: Sodium is…
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.